# Carlyle Group Inc.: financial statements, quarterly

CG · Nasdaq · CIK 1527166 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cg.md) · [Financials](/companies/cg/financials.md) · [Filings](/companies/cg/filings.md) · [Insiders](/companies/cg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [717](/filings/0001527166-24-000079.md) | [926 d](/filings/0001527166-26-000009.md) | [688](/filings/0001527166-25-000071.md) | [1,070](/filings/0001527166-25-000104.md) | [2,635](/filings/0001527166-25-000125.md) | [1,033 d](/filings/0001527166-26-000009.md) | [973](/filings/0001527166-26-000027.md) | [1,573](/filings/0001527166-26-000045.md) | [333](/filings/0001527166-25-000125.md) | [1,901 d](/filings/0001527166-26-000009.md) | [254](/filings/0001527166-26-000027.md) | [1,124](/filings/0001527166-26-000045.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [31.4](/filings/0001527166-24-000079.md) | [32.0 d](/filings/0001527166-26-000009.md) | [30.8](/filings/0001527166-25-000071.md) | [30.4](/filings/0001527166-25-000104.md) | [30.3](/filings/0001527166-25-000125.md) | [29.5 d](/filings/0001527166-26-000009.md) | [27.8](/filings/0001527166-26-000027.md) | [28.0](/filings/0001527166-26-000045.md) | [29.8](/filings/0001527166-25-000125.md) | [38.3 d](/filings/0001527166-26-000009.md) | [38.6](/filings/0001527166-26-000027.md) | [38.2](/filings/0001527166-26-000045.md) |
| Income tax | $m | [41.2](/filings/0001527166-24-000079.md) | [(172) d](/filings/0001527166-26-000009.md) | [21.9](/filings/0001527166-25-000071.md) | [69.5](/filings/0001527166-25-000104.md) | [173](/filings/0001527166-25-000125.md) | [38.1 d](/filings/0001527166-26-000009.md) | [12.4](/filings/0001527166-26-000027.md) | [113](/filings/0001527166-26-000045.md) | [(26.7)](/filings/0001527166-25-000125.md) | [116 d](/filings/0001527166-26-000009.md) | [(37.1)](/filings/0001527166-26-000027.md) | [49.0](/filings/0001527166-26-000045.md) |
| Net income | $m | [81.3](/filings/0001527166-24-000079.md) | [(692) d](/filings/0001527166-26-000009.md) | [65.6](/filings/0001527166-25-000071.md) | [148](/filings/0001527166-25-000104.md) | [596](/filings/0001527166-25-000125.md) | [211 d](/filings/0001527166-26-000009.md) | [130](/filings/0001527166-26-000027.md) | [320](/filings/0001527166-26-000045.md) | [0.9](/filings/0001527166-25-000125.md) | [358 d](/filings/0001527166-26-000009.md) | [(132)](/filings/0001527166-26-000027.md) | [137](/filings/0001527166-26-000045.md) |
| Diluted EPS | $ per share | [0.22](/filings/0001527166-24-000079.md) | not reported | [0.18](/filings/0001527166-25-000071.md) | [0.40](/filings/0001527166-25-000104.md) | [1.63](/filings/0001527166-25-000125.md) | not reported | [0.35](/filings/0001527166-26-000027.md) | [0.87](/filings/0001527166-26-000045.md) | [0.00](/filings/0001527166-25-000125.md) | not reported | [(0.37)](/filings/0001527166-26-000027.md) | [0.37](/filings/0001527166-26-000045.md) |
| Basic EPS | $ per share | [0.23](/filings/0001527166-24-000079.md) | not reported | [0.18](/filings/0001527166-25-000071.md) | [0.41](/filings/0001527166-25-000104.md) | [1.67](/filings/0001527166-25-000125.md) | not reported | [0.36](/filings/0001527166-26-000027.md) | [0.89](/filings/0001527166-26-000045.md) | [0.00](/filings/0001527166-25-000125.md) | not reported | [(0.37)](/filings/0001527166-26-000027.md) | [0.38](/filings/0001527166-26-000045.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.3](/filings/0001527166-24-000079.md) | [1.4](/filings/0001527166-26-000009.md) | [1.3](/filings/0001527166-25-000071.md) | [0.9](/filings/0001527166-25-000104.md) | [1.4](/filings/0001527166-25-000125.md) | [1.3](/filings/0001527166-26-000009.md) | [1.2](/filings/0001527166-26-000027.md) | [1.3](/filings/0001527166-26-000045.md) | [2.2](/filings/0001527166-25-000125.md) | [2.0](/filings/0001527166-26-000045.md) | [1.7](/filings/0001527166-26-000027.md) | [1.3](/filings/0001527166-26-000045.md) |
| Total assets | $bn | [21.0](/filings/0001527166-23-000084.md) | [21.2](/filings/0001527166-25-000006.md) | [20.8](/filings/0001527166-24-000051.md) | [22.3](/filings/0001527166-24-000067.md) | [22.7](/filings/0001527166-24-000079.md) | [23.1](/filings/0001527166-26-000009.md) | [24.1](/filings/0001527166-25-000071.md) | [25.1](/filings/0001527166-25-000104.md) | [27.1](/filings/0001527166-25-000125.md) | [29.1](/filings/0001527166-26-000045.md) | [29.8](/filings/0001527166-26-000027.md) | [28.2](/filings/0001527166-26-000045.md) |
| Total liabilities | $bn | [14.5](/filings/0001527166-23-000084.md) | [15.4](/filings/0001527166-25-000006.md) | [15.1](/filings/0001527166-24-000051.md) | [16.6](/filings/0001527166-24-000067.md) | [16.3](/filings/0001527166-24-000079.md) | [16.8](/filings/0001527166-26-000009.md) | [17.7](/filings/0001527166-25-000071.md) | [18.4](/filings/0001527166-25-000104.md) | [20.2](/filings/0001527166-25-000125.md) | [22.1](/filings/0001527166-26-000045.md) | [22.5](/filings/0001527166-26-000027.md) | [21.0](/filings/0001527166-26-000045.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [6.5](/filings/0001527166-24-000079.md) | [5.8](/filings/0001527166-26-000009.md) | [5.7](/filings/0001527166-25-000104.md) | [5.7](/filings/0001527166-25-000125.md) | [6.3](/filings/0001527166-25-000125.md) | [6.3](/filings/0001527166-26-000045.md) | [6.4](/filings/0001527166-26-000045.md) | [6.7](/filings/0001527166-26-000045.md) | [6.8](/filings/0001527166-25-000125.md) | [7.1](/filings/0001527166-26-000045.md) | [7.4](/filings/0001527166-26-000045.md) | [7.2](/filings/0001527166-26-000045.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [800 d](/filings/0001527166-24-000079.md) | [254 d](/filings/0001527166-26-000009.md) | [71.1](/filings/0001527166-25-000071.md) | [(1,270) d](/filings/0001527166-25-000104.md) | [792 d](/filings/0001527166-25-000125.md) | [(353) d](/filings/0001527166-26-000009.md) | [(352)](/filings/0001527166-26-000027.md) | [(169) d](/filings/0001527166-26-000045.md) | [(1,560) d](/filings/0001527166-25-000125.md) | [(1,195) d](/filings/0001527166-26-000009.md) | [(1,242)](/filings/0001527166-26-000027.md) | [(0.5) d](/filings/0001527166-26-000045.md) |
| Capital expenditure | $m | [17.1 d](/filings/0001527166-24-000079.md) | [17.0 d](/filings/0001527166-26-000009.md) | [14.2](/filings/0001527166-25-000071.md) | [17.7 d](/filings/0001527166-25-000104.md) | [19.1 d](/filings/0001527166-25-000125.md) | [26.7 d](/filings/0001527166-26-000009.md) | [16.7](/filings/0001527166-26-000027.md) | [17.5 d](/filings/0001527166-26-000045.md) | [23.2 d](/filings/0001527166-25-000125.md) | [42.0 d](/filings/0001527166-26-000009.md) | [28.1](/filings/0001527166-26-000027.md) | [32.0 d](/filings/0001527166-26-000045.md) |
| Dividends paid | $m | [126 d](/filings/0001527166-24-000079.md) | [126 d](/filings/0001527166-26-000009.md) | [127](/filings/0001527166-25-000071.md) | [126 d](/filings/0001527166-25-000104.md) | [126 d](/filings/0001527166-25-000125.md) | [125 d](/filings/0001527166-26-000009.md) | [126](/filings/0001527166-26-000027.md) | [126 d](/filings/0001527166-26-000045.md) | [127 d](/filings/0001527166-25-000125.md) | [126 d](/filings/0001527166-26-000009.md) | [126](/filings/0001527166-26-000027.md) | [126 d](/filings/0001527166-26-000045.md) |
| Share repurchases | $m | [42.9 d](/filings/0001527166-24-000079.md) | [(0.2) d](/filings/0001527166-26-000009.md) | [150](/filings/0001527166-25-000071.md) | [178 d](/filings/0001527166-25-000104.md) | [151 d](/filings/0001527166-25-000125.md) | [75.8 d](/filings/0001527166-26-000009.md) | [177](/filings/0001527166-26-000027.md) | [104 d](/filings/0001527166-26-000045.md) | [203 d](/filings/0001527166-25-000125.md) | [204 d](/filings/0001527166-26-000009.md) | [205](/filings/0001527166-26-000027.md) | [304 d](/filings/0001527166-26-000045.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [367](/filings/0001527166-23-000084.md) | [365](/filings/0001527166-24-000051.md) | [361](/filings/0001527166-24-000067.md) | [364](/filings/0001527166-24-000079.md) | [369](/filings/0001527166-25-000071.md) | [367](/filings/0001527166-25-000104.md) | [365](/filings/0001527166-25-000125.md) | [366](/filings/0001527166-26-000027.md) | [367](/filings/0001527166-26-000045.md) | [376](/filings/0001527166-25-000125.md) | [359](/filings/0001527166-26-000027.md) | [367](/filings/0001527166-26-000045.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 356,332,798 at 2026-08-04, from the cover of the [10-Q filed 2026-08-10](/filings/0001527166-26-000045.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.